Clinical Trials Logo

Aortic Valve, Bicuspid clinical trials

View clinical trials related to Aortic Valve, Bicuspid.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03139786 Recruiting - Clinical trials for Aortic Valve, Bicuspid

Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia

Start date: October 14, 2011
Phase:
Study type: Observational

The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of 2 sigmoids instead of 3. This is the most common cardiac congenital anomaly affecting 0.5 to 2% of the population The general rule. BVA may be associated with structural damage to the ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm and acute aortic accidents. Recent data from the literature have revealed that the natural history of BVA is marked by a possible development towards significant valvulopathy and / or an ascending aortic aneurysm often requiring surgical treatment. However, the natural history of bicuspid disease remains poorly understood and the prognostic factors for progression to severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be determined.